Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis. NICE technology appraisal guidance 276
National Institute for Health and Care Excellence (NICE)
Record ID 32018011403
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta276
Year Published:
2013
URL for published report:
https://www.nice.org.uk/guidance/ta276
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Cystic Fibrosis
- Tobramycin
- Dry Powder Inhalers
- Anti-Bacterial Agents
- Colistin
- Pseudomonas Infections
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.